Skip to main content
. 2022 Nov 28;2022:5759740. doi: 10.1155/2022/5759740

Table 4.

Comparing hematological parameters before and after administration of ferric carboxymaltose by the severity of anemia

Severity of anemia Parameters N At baseline (mean ± SD) At 4 weeks (mean ± SD) Mean improvement ± SD
Severe Hemoglobin (g/dL) 103 6.49 ± 0.41 10.09 ± 1.11 3.6 ± 1.08
Ferritin (μg/L) 46 51.88 ± 58.3 68.84 ± 39.47 16.96 ± 72.52NS
RBC (mn/mm3) 38 3.53 ± 0.59 4.56 ± 0.89 1.03 ± 1.22
Hematocrit (%) 37 32.82 ± 7.74 32.22 ± 14.28 0.6 ± 10.7NS
MCV (fL) 46 75.82 ± 11.35 68.61 ± 25.62 7.2 ± 27.87NS
MCH (pg) 45 25.75 ± 6.15 28.03 ± 5.59 2.28 ± 6.16#
MCHC (g/dL) 44 28.65 ± 3.52 29.67 ± 10.52 1.03 ± 9.34NS

Moderate Hemoglobin (g/dL) 978 8.14 ± 0.72 10.87 ± 1.03 2.74 ± 0.98
Ferritin (μg/L) 203 36.13 ± 43.7 69.12 ± 73.88 33 ± 48.54
RBC (mn/mm3) 174 4.21 ± 0.67 4.68 ± 0.92 0.47 ± 1.04
Hematocrit (%) 165 33.43 ± 5.09 35.89 ± 5.92 2.46 ± 4.79
MCV (fL) 202 68.07 ± 9.35 77.64 ± 14.96 9.58 ± 17.49
MCH (pg) 200 24.04 ± 6.38 27.73 ± 6.23 3.68 ± 7.6
MCHC (g/dL) 198 29.75 ± 2.83 31.22 ± 16.01 1.48 ± 15.39NS

Mild Hemoglobin (g/dL) 26 10.18 ± 0.25 12.17 ± 0.77 1.99 ± 0.8
Ferritin (μg/L) 2 8 ± 9.9 37.1 ± 32.39 29.1 ± 22.49NS
RBC (mn/mm3) 2 3.93 ± 0.1 4.13 ± 0.18 0.2 ± 0.28NS
Hematocrit (%) 2 32.25 ± 1.34 34.25 ± 2.33 2 ± 0.99NS
MCV (fL) 1 61.4 ± 0 80.6 ± 0
MCH (pg) 2 26.15 ± 8.27 33.4 ± 9.33 7.25 ± 1.06NS
MCHC (g/dL) 2 31.6 ± 2.55 31.65 ± 2.33 0.05 ± 4.88NS

P value <0.001, statistically significant difference; NS-P value >0.05, nonsignificant difference. %-percentage; μg/L-micrograms per liter; fL-femtoliters; g/dL-grams per deciliter; MCH-mean corpuscular hemoglobin; MCHC-mean corpuscular hemoglobin concentration; MCV-mean corpuscular volume; mn/mm3-million per millimeter cube; N-number of participants; pg-pictograms; RBC-red blood cell; SD-standard deviation. Note: 4 weeks is 4 ± 1 week.